OrthoPediatrics Corp (FRA:2X7)
€ 19.1 +0.30 (+1.6%) Market Cap: 526.00 Mil Enterprise Value: 572.51 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 85/100

Q2 2025 OrthoPediatrics Corp Earnings Call Transcript

Aug 5, 2025 / 08:30 PM GMT
Release Date Price: €17.7 (+1.14%)

Key Points

Positve
  • OrthoPediatrics Corp (KIDS) reported record revenue with a global growth of 16% in Q2 2025.
  • The company achieved significant market share gains across all business segments, particularly in scoliosis, trauma, and non-surgical specialty bracing.
  • International sales were strong, driven by surgical demand in Europe and the Middle East.
  • The company announced several milestones, including new clinic openings in the US and its first international clinic in Ireland.
  • OrthoPediatrics Corp (KIDS) raised its revenue guidance for 2025, reflecting confidence in continued growth and market expansion.
Negative
  • Gross profit margin decreased to 72% from 77% in the same quarter last year, primarily due to higher international set sales and 7D growth.
  • Operating expenses increased by 18%, driven by restructuring charges and increased personnel costs.
  • The company experienced slower growth in international revenues, particularly due to lower trauma and deformity set sales in Latin America.
  • There was a slowdown in elective limb deformity case scheduling early in the quarter, impacting growth.
  • The company drew down $25 million on its line of credit, indicating potential cash flow challenges.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KIDS.OQ - Orthopediatrics Corp
Q2 2025 OrthoPediatrics Corp Earnings Call
Aug 05, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Orthopediatric Corporation's 2nd quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Hannah Jeffrey from the Gilmartin Group for a few introductory comments. Please begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for joining today's call. With me from the company are Dave Bailey, President and Chief
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot